Innate receptors and cellular defense against pulmonary infections

Journal of Immunology

Volumn 193, Issue 8, 2014, Pages 3842-3850

  Werner, Jessica L ^a   Steele, Chad ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD209 ANTIGEN; DECTIN 2; LECTIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RECEPTOR; RETINOIC ACID INDUCIBLE GENE I LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR B; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; ASTHMA; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DENDRITIC CELL; DISEASE EXACERBATION; FUNGUS IMMUNITY; GAMMA DELTA T LYMPHOCYTE; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; NEUTROPHIL; NONHUMAN; PARASITE IMMUNITY; REVIEW; VIRUS IMMUNITY; EPITHELIUM CELL; IMMUNOLOGY; LUNG DISEASE; MICROBIOLOGY; PARASITOLOGY; RESPIRATORY TRACT INFECTION;

DENDRITIC CELLS; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; LUNG DISEASES; MACROPHAGES, ALVEOLAR; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RESPIRATORY TRACT INFECTIONS;

EID: 84907487375     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400978     Document Type: Review

References (146)

1. Sessa, R., P. M. Di, G. Schiavoni, I. Santino, A. Altieri, S. Pinelli, and P. M. Del. 2002. Microbiological indoor air quality in healthy buildings. New Microbiol. 25: 51-56.
2. Menegueti, M. G., L. R. Ferreira, M. F. Silva, A. S. Silva, and F. Bellissimo-Rodrigues. 2013. Assessment of microbiological air quality in hemato-oncology units and its relationship with the occurrence of invasive fungal infections: an integrative review. Rev. Soc. Bras. Med. Trop. 46: 391-396.
3. Edwards, M. R., N. W. Bartlett, T. Hussell, P. Openshaw, and S. L. Johnston. 2012. The microbiology of asthma. Nat. Rev. Microbiol. 10: 459-471.
4. Rangelov, K., and S. Sethi. 2014. Role of infections. Clin. Chest Med. 35: 87-100.
5. Chaput, C., L. E. Sander, N. Suttorp, and B. Opitz. 2013. NOD-Like Receptors in Lung Diseases. Front. Immunol. 4: 393.
6. Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. Cézard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
7. O'Neill, L. A., D. Golenbock, and A. G. Bowie. 2013. The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol. 13: 453-460.
8. Liu, D., A. M. Rhebergen, and S. C. Eisenbarth. 2013. Licensing Adaptive Immunity by NOD-Like Receptors. Front. Immunol. 4: 486.
9. Regueiro, V., D. Moranta, C. G. Frank, E. Larrarte, J. Margareto, C. March, J. Garmendia, and J. A. Bengoechea. 2011. Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner. Cell. Microbiol. 13: 135-153.
10. Travassos, L. H., L. A. Carneiro, S. E. Girardin, I. G. Boneca, R. Lemos, M. T. Bozza, R. C. Domingues, A. J. Coyle, J. Bertin, D. J. Philpott, and M. C. Plotkowski. 2005. Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J. Biol. Chem. 280: 36714-36718.
11. Davis, K. M., S. Nakamura, and J. N. Weiser. 2011. Nod2 sensing of lysozymedigested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J. Clin. Invest. 121: 3666-3676.
12. Kapetanovic, R., G. Jouvion, C. Fitting, M. Parlato, C. Blanchet, M. Huerre, J. M. Cavaillon, and M. Adib-Conquy. 2010. Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia. Microbes Infect. 12: 759-767.
13. Divangahi, M., S. Mostowy, F. Coulombe, R. Kozak, L. Guillot, F. Veyrier, K. S. Kobayashi, R. A. Flavell, P. Gros, and M. A. Behr. 2008. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 181: 7157-7165.
14. Allen, I. C., M. A. Scull, C. B. Moore, E. K. Holl, E. McElvania-TeKippe, D. J. Taxman, E. H. Guthrie, R. J. Pickles, and J. P. Ting. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30: 556-565.
15. Segovia, J., A. Sabbah, V. Mgbemena, S. Y. Tsai, T. H. Chang, M. T. Berton, I. R. Morris, I. C. Allen, J. P. Ting, and S. Bose. 2012. TLR2/MyD88/NF-kB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE 7: e29695.
16. Vabret, N., and J. M. Blander. 2013. Sensing microbial RNA in the cytosol. Front. Immunol. 4: 468.
17. Saito,T., R.Hirai, Y. M. Loo, D.Owen, C. L. Johnson, S. C. Sinha, S. Akira, T. Fujita, and M. Gale, Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA 104: 582-587.
18. Si-Tahar, M., F. Blanc, L. Furio, D. Chopy, V. Balloy, M. Lafon, M. Chignard, L. Fiette, F. Langa, P. Charneau, and J. Pothlichet. 2014. Protective role of LGP2 in influenza virus pathogenesis. J. Infect. Dis. 210: 214-223.
19. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NFkappaB and IRF 3. Cell 122: 669-682.
20. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988.
21. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
22. Loo, Y. M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. García-Sastre, M. G. Katze, and M. Gale, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345.
23. Liao, S., X. Bao, T. Liu, S. Lai, K. Li, R. P. Garofalo, and A. Casola. 2008. Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J. Gen. Virol. 89: 1978-1986.
24. Baños-Lara, Mdel R., A. Ghosh, and A. Guerrero-Plata. 2013. Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J. Virol. 87: 1242-1251.
25. Childs, K., N. Stock, C. Ross, J. Andrejeva, L. Hilton, M. Skinner, R. Randall, and S. Goodbourn. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359: 190-200.
26. Yount, J. S., L. Gitlin, T. M. Moran, and C. B. López. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J. Immunol. 180: 4910-4918.
27. Kim, W. K., D. Jain, M. D. Sánchez, C. J. Koziol-White, K. Matthews, M. Q. Ge, A. Haczku, R. A. Panettieri, Jr., M. B. Frieman, and C. B. López. 2014. Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation. Am. J. Respir. Crit. Care Med. 189: 437-448.
28. Chiang, H. S., Y. Zhao, J. H. Song, S. Liu, N. Wang, C. Terhorst, A. H. Sharpe, M. Basavappa, K. L. Jeffrey, and H. C. Reinecker. 2014. GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses. Nat. Immunol. 15: 63-71.
29. Mibayashi, M., L. Martínez-Sobrido, Y. M. Loo, W. B. Cárdenas, M. Gale, Jr., and A. García-Sastre. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 81: 514-524.
30. Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 101: 17264-17269.
31. Siu, K. L., M. L. Yeung, K. H. Kok, K. S. Yuen, C. Kew, P. Y. Lui, C. P. Chan, H. Tse, P. C. Woo, K. Y. Yuen, and D. Y. Jin. 2014. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J. Virol. 88: 4866-4876.
32. Monroe, K. M., S. M. McWhirter, and R. E. Vance. 2009. Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog. 5: e1000665.
33. Hardison, S. E., and G. D. Brown. 2012. C-type lectin receptors orchestrate antifungal immunity. Nat. Immunol. 13: 817-822.
34. van den Berg, L. M., S. I. Gringhuis, and T. B. Geijtenbeek. 2012. An evolutionary perspective on C-type lectins in infection and immunity. Ann. N. Y. Acad. Sci. 1253: 149-158.
35. Sancho, D., and C. Reis e Sousa. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30: 491-529.
36. Ishikawa, E., T. Ishikawa, Y. S. Morita, K. Toyonaga, H. Yamada, O. Takeuchi, T. Kinoshita, S. Akira, Y. Yoshikai, and S. Yamasaki. 2009. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206: 2879-2888.
37. Steichen, A. L., B. J. Binstock, B. B. Mishra, and J. Sharma. 2013. C-type lectin receptor Clec4d plays a protective role in resolution of Gram-negative pneumonia. J. Leukoc. Biol. 94: 393-398.
38. Geijtenbeek, T. B., P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram- Panday, G. C. van Duijnhoven, G. Kraal, A. J. van Oosterhout, and Y. van Kooyk. 2002. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100: 2908-2916.
39. Wang, H., V. LeBert, C. Y. Hung, K. Galles, S. Saijo, X. Lin, G. T. Cole, B. S. Klein, and M. Wüthrich. 2014. C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America. J. Immunol. 192: 1107-1119.
40. Mansour, M. K., E. Latz, and S. M. Levitz. 2006. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 176: 3053-3061.
41. Hillaire, M. L., N. J. Nieuwkoop, A. C. Boon, G. de Mutsert, S. E. Vogelzang-van Trierum, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2013. Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells. PLoS ONE 8: e56164.
42. Yang, Z. Y., Y. Huang, L. Ganesh, K. Leung, W. P. Kong, O. Schwartz, K. Subbarao, and G. J. Nabel. 2004. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78: 5642-5650.
43. Werner, J. L., A. E. Metz, D. Horn, T. R. Schoeb, M. M. Hewitt, L. M. Schwiebert, I. Faro-Trindade, G. D. Brown, and C. Steele. 2009. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182: 4938-4946.
44. Viriyakosol, S., Mdel. P. Jimenez, M. A. Gurney, M. E. Ashbaugh, and J. Fierer. 2013. Dectin-1 is required for resistance to coccidioidomycosis in mice. MBio 4: e00597-e12.
45. Steele, C., L. Marrero, S. Swain, A. G. Harmsen, M. Zheng, G. D. Brown, S. Gordon, J. E. Shellito, and J. K. Kolls. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J. Exp. Med. 198: 1677-1688.
46. Yadav, M., and J. S. Schorey. 2006. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108: 3168-3175.
47. Das, R., M. S. Koo, B. H. Kim, S. T. Jacob, S. Subbian, J. Yao, L. Leng, R. Levy, C. Murchison, W. J. Burman, et al. 2013. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 110: E2997-E3006.
48. Marakalala, M. J., R. Guler, L. Matika, G. Murray, M. Jacobs, F. Brombacher, A. G. Rothfuchs, A. Sher, and G. D. Brown. 2011. The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in mice. Microbes Infect. 13: 198-201.
49. Fei, M., S. Bhatia, T. B. Oriss, M. Yarlagadda, A. Khare, S. Akira, S. Saijo, Y. Iwakura, B. A. Fallert Junecko, T. A. Reinhart, et al. 2011. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc. Natl. Acad. Sci. USA 108: 5360-5365.
50. Lilly, L. M., M. A. Gessner, C. W. Dunaway, A. E. Metz, L. Schwiebert, C. T. Weaver, G. D. Brown, and C. Steele. 2012. The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J. Immunol. 189: 3653-3660.
51. Ramaprakash, H., T. Ito, T. J. Standiford, S. L. Kunkel, and C. M. Hogaboam. 2009. Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect. Immun. 77: 108-119.
52. Moreira, A. P., K. A. Cavassani, U. B. Ismailoglu, R. Hullinger, M. P. Dunleavy, D. A. Knight, S. L. Kunkel, S. Uematsu, S. Akira, and C. M. Hogaboam. 2011. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J. Clin. Invest. 121: 4420-4432.
53. Mintz-Cole, R. A., A. M. Gibson, S. A. Bass, A. L. Budelsky, T. Reponen, and G. K. Hershey. 2012. Dectin-1 and IL-17A suppress murine asthma induced by Aspergillus versicolor but not Cladosporium cladosporioides due to differences in β-glucan surface exposure. J. Immunol. 189: 3609-3617.
54. Mintz-Cole, R. A., E. B. Brandt, S. A. Bass, A. M. Gibson, T. Reponen, and G. K. Khurana Hershey. 2013. Surface availability of beta-glucans is critical determinant of host immune response to Cladosporium cladosporioides. J. Allergy Clin. Immunol. 132: 159-169.
55. Willment, J. A., S. Gordon, and G. D. Brown. 2001. Characterization of the human beta-glucan receptor and its alternatively spliced isoforms. J. Biol. Chem. 276: 43818-43823.
56. Schlesinger, L. S., T. M. Kaufman, S. Iyer, S. R. Hull, and L. K. Marchiando. 1996. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol. 157: 4568-4575.
57. Zamze, S., L. Martinez-Pomares, H. Jones, P. R. Taylor, R. J. Stillion, S. Gordon, and S. Y. Wong. 2002. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor. J. Biol. Chem. 277: 41613-41623.
58. Dan, J. M., R. M. Kelly, C. K. Lee, and S. M. Levitz. 2008. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect. Immun. 76: 2362-2367.
59. Zhang, S. S., C. G. Park, P. Zhang, S. S. Bartra, G. V. Plano, J. D. Klena, M. Skurnik, B. J. Hinnebusch, and T. Chen. 2008. Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. J. Biol. Chem. 283: 31511-31521.
60. Do, Y., A. M. Didierlaurent, S. Ryu, H. Koh, C. G. Park, S. Park, D. S. Perlin, B. S. Powell, and R. M. Steinman. 2012. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor. Vaccine 30: 6359-6367.
61. Dong, H., O. Stanek, F. R. Salvador, U. Länger, E. Morillon, C. Ung, P. Sebo, C. Leclerc, and L. Majlessi. 2013. Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells. Mucosal Immunol. 6: 522-534.
62. Canton, J., D. Neculai, and S. Grinstein. 2013. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 13: 621-634.
63. Dunne, D. W., D. Resnick, J. Greenberg, M. Krieger, and K. A. Joiner. 1994. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91: 1863-1867.
64. Arredouani, M. S., Z. Yang, A. Imrich, Y. Ning, G. Qin, and L. Kobzik. 2006. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am. J. Respir. Cell Mol. Biol. 35: 474-478.
65. Ozment, T. R., T. Ha, K. F. Breuel, T. R. Ford, D. A. Ferguson, J. Kalbfleisch, J. B. Schweitzer, J. L. Kelley, C. Li, and D. L. Williams. 2012. Scavenger receptor class a plays a central role in mediating mortality and the development of the pro-inflammatory phenotype in polymicrobial sepsis. PLoS Pathog. 8: e1002967.
66. Qiu, Y., J. K. Dayrit, M. J. Davis, J. F. Carolan, J. J. Osterholzer, J. L. Curtis, and M. A. Olszewski. 2013. Scavenger receptor A modulates the immune response to pulmonary Cryptococcus neoformans infection. J. Immunol. 191: 238-248.
67. Blanchet, C., G. Jouvion, C. Fitting, J. M. Cavaillon, and M. Adib-Conquy. 2014. Protective or deleterious role of scavenger receptors SR-A and CD36 on host resistance to Staphylococcus aureus depends on the site of infection. PLoS ONE 9: e87927.
68. Arredouani, M., Z. Yang, Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200: 267-272.
69. Palecanda, A., J. Paulauskis, E. Al-Mutairi, A. Imrich, G. Qin, H. Suzuki, T. Kodama, K. Tryggvason, H. Koziel, and L. Kobzik. 1999. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J. Exp. Med. 189: 1497-1506.
70. Arredouani, M. S., F. Franco, A. Imrich, A. Fedulov, X. Lu, D. Perkins, R. Soininen, K. Tryggvason, S. D. Shapiro, and L. Kobzik. 2007. Scavenger Receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation. J. Immunol. 178: 5912-5920.
71. Ghosh, S., D. Gregory, A. Smith, and L. Kobzik. 2011. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. Am. J. Respir. Cell Mol. Biol. 45: 1036-1044.
72. Gowda, N. M., X. Wu, S. Kumar, M. Febbraio, and D. C. Gowda. 2013. CD36 contributes to malaria parasite-induced pro-inflammatory cytokine production and NK and T cell activation by dendritic cells. PLoS ONE 8: e77604.
73. Lovegrove, F. E., S. A. Gharib, L. Peña-Castillo, S. N. Patel, J. T. Ruzinski, T. R. Hughes, W. C. Liles, and K. C. Kain. 2008. Parasite burden and CD36- mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 4: e1000068.
74. Drage, M. G., N. D. Pecora, A. G. Hise, M. Febbraio, R. L. Silverstein, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2009. TLR2 and its coreceptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell. Immunol. 258: 29-37.
75. Court, N., V. Vasseur, R. Vacher, C. Frémond, Y. Shebzukhov, V. V. Yeremeev, I. Maillet, S. A. Nedospasov, S. Gordon, P. G. Fallon, et al. 2010. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J. Immunol. 184: 7057-7070.
76. Shimaoka, T., N. Kume, M. Minami, K. Hayashida, T. Sawamura, T. Kita, and S. Yonehara. 2001. LOX-1 supports adhesion of Gram-positive and Gramnegative bacteria. J. Immunol. 166: 5108-5114.
77. Zhang, P., M. C. Liu, L. Cheng, M. Liang, H. L. Ji, and J. Fu. 2009. Blockade of LOX-1 prevents endotoxin-induced acute lung inflammation and injury in mice. J. Innate Immun. 1: 358-365.
78. Dieudonné, A., D. Torres, S. Blanchard, S. Taront, P. Jeannin, Y. Delneste, M. Pichavant, F. Trottein, and P. Gosset. 2012. Scavenger receptors in human airway epithelial cells: role in response to double-stranded RNA. PLoS ONE 7: e41952.
79. Shimaoka, T., N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, and S. Yonehara. 2000. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 275: 40663-40666.
80. Matloubian, M., A. David, S. Engel, J. E. Ryan, and J. G. Cyster. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1: 298-304.
81. Lee, L. N., E. O. Ronan, C. de Lara, K. L. Franken, T. H. Ottenhoff, E. Z. Tchilian, and P. C. Beverley. 2011. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis. Infect. Immun. 79: 3328-3337.
82. Germanov, E., L. Veinotte, R. Cullen, E. Chamberlain, E. C. Butcher, and B. Johnston. 2008. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J. Immunol. 181: 81-91.
83. Olszak, T., D. An, S. Zeissig, M. P. Vera, J. Richter, A. Franke, J. N. Glickman, R. Siebert, R. M. Baron, D. L. Kasper, and R. S. Blumberg. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489-493.
84. Bartlett, J. A., A. J. Fischer, and P. B. McCray, Jr. 2008. Innate immune functions of the airway epithelium. Contrib. Microbiol. 15: 147-163.
85. Sanders, C. J., P. C. Doherty, and P. G. Thomas. 2011. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res. 343: 13-21.
86. Chuquimia, O. D., D. H. Petursdottir, N. Periolo, and C. Fernández. 2013. Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect. Immun. 81: 381-389.
87. Adler, K. B., M. J. Tuvim, and B. F. Dickey. 2013. Regulated mucin secretion from airway epithelial cells. Front. Endocrinol. (Lausanne) 4: 129.
88. Rada, B., and T. L. Leto. 2008. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 15: 164-187.
89. Vareille, M., E. Kieninger, M. R. Edwards, and N. Regamey. 2011. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 24: 210-229.
90. Sajjan, U. S. 2013. Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr. Opin. Pulm. Med. 19: 125-132.
91. John, G., A. O. Yildirim, B. K. Rubin, D. C. Gruenert, and M. O. Henke. 2010. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am. J. Respir. Cell Mol. Biol. 42: 424-431.
92. Parker, D., and A. Prince. 2013. Epithelial uptake of flagella initiates proinflammatory signaling. PLoS One 8: e59932.
93. Xie, X. H., H. K. Law, L. J. Wang, X. Li, X. Q. Yang, and E. M. Liu. 2009. Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatr. Res. 65: 156-162.
94. Hussell, T., and T. J. Bell. 2014. Alveolar macrophages: plasticity in a tissuespecific context. Nat. Rev. Immunol. 14: 81-93.
95. Hiraiwa, K., and S. F. van Eeden. 2013. Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants. Mediators Inflamm. 2013: 619523.
96. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
97. Boorsma, C. E., C. Draijer, and B. N. Melgert. 2013. Macrophage heterogeneity in respiratory diseases. Mediators Inflamm. 2013: 769214.
98. Landsman, L., and S. Jung. 2007. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol. 179: 3488-3494.
99. Guilliams, M., I. De Kleer, S. Henri, S. Post, L. Vanhoutte, S. De Prijck, K. Deswarte, B. Malissen, H. Hammad, and B. N. Lambrecht. 2013. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210: 1977-1992.
100. Yona, S., K. W. Kim, Y. Wolf, A. Mildner, D. Varol, M. Breker, D. Strauss-Ayali, S. Viukov, M. Guilliams, A. Misharin, et al. 2013. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38: 79-91.
101. Jenkins, S. J., D. Ruckerl, P. C. Cook, L. H. Jones, F. D. Finkelman, N. van Rooijen, A. S. MacDonald, and J. E. Allen. 2011. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284-1288.
102. Empey, K. M., M. Hollifield, and B. A. Garvy. 2007. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice. Infect. Immun. 75: 3382-3393.
103. Mircescu, M. M., L. Lipuma, N. van Rooijen, E. G. Pamer, and T. M. Hohl. 2009. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J. Infect. Dis. 200: 647-656.
104. Moreno, G., A. Errea, L. Van Maele, R. Roberts, H. Léger, J. C. Sirard, A. Benecke, M. Rumbo, and D. Hozbor. 2013. Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection. Microbes Infect. 15: 708-718.
105. Young, R. L., K. C. Malcolm, J. E. Kret, S. M. Caceres, K. R. Poch, D. P. Nichols, J. L. Taylor-Cousar, M. T. Saavedra, S. H. Randell, M. L. Vasil, et al. 2011. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS ONE 6: e23637.
106. Hahn, I., A. Klaus, A. K. Janze, K. Steinwede, N. Ding, J. Bohling, C. Brumshagen, H. Serrano, F. Gauthier, J. C. Paton, et al. 2011. Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice. Infect. Immun. 79: 4893-4901.
107. Cai, S., S. Batra, S. A. Lira, J. K. Kolls, and S. Jeyaseelan. 2010. CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs. J. Immunol. 185: 6214-6225.
108. Cowburn, A. S., A. M. Condliffe, N. Farahi, C. Summers, and E. R. Chilvers. 2008. Advances in neutrophil biology: clinical implications. Chest 134: 606-612.
109. Hahn, S., S. Giaglis, C. S. Chowdhury, I. Hösli, and P. Hasler. 2013. Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology. [Published erratum appears in 2013 Semin. Immunopathol. 35: 531.] Semin. Immunopathol. 35: 439-453.
110. Guilliams, M., B. N. Lambrecht, and H. Hammad. 2013. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol. 6: 464-473.
111. Lambrecht, B. N., and H. Hammad. 2012. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu. Rev. Immunol. 30: 243-270.
112. Helft, J., B. Manicassamy, P. Guermonprez, D. Hashimoto, A. Silvin, J. Agudo, B. D. Brown, M. Schmolke, J. C. Miller, M. Leboeuf, et al. 2012. Crosspresenting CD103+ dendritic cells are protected from influenza virus infection. J. Clin. Invest. 122: 4037-4047.
113. Davidson, S., G. Kaiko, Z. Loh, A. Lalwani, V. Zhang, K. Spann, S. Y. Foo, N. Hansbro, S. Uematsu, S. Akira, et al. 2011. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J. Immunol. 186: 5938-5948.
114. Schreiber, H. A., J. S. Harding, O. Hunt, C. J. Altamirano, P. D. Hulseberg, D. Stewart, Z. Fabry, and M. Sandor. 2011. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J. Clin. Invest. 121: 3902-3913.
115. Vantourout, P., and A. Hayday. 2013. Six-of-the-best: unique contributions of gd T cells to immunology. Nat. Rev. Immunol. 13: 88-100.
116. Prinz, I., B. Silva-Santos, and D. J. Pennington. 2013. Functional development of gd T cells. Eur. J. Immunol. 43: 1988-1994.
117. Augustin, A., R. T. Kubo, and G. K. Sim. 1989. Resident pulmonary lymphocytes expressing the gamma/delta T-cell receptor. Nature 340: 239-241.
118. Moore, T. A., B. B. Moore, M. W. Newstead, and T. J. Standiford. 2000. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J. Immunol. 165: 2643-2650.
119. Saunders, B. M., A. A. Frank, A. M. Cooper, and I. M. Orme. 1998. Role of gamma delta T cells in immunopathology of pulmonary Mycobacterium avium infection in mice. Infect. Immun. 66: 5508-5514.
120. Cheng, P., T. Liu, W. Y. Zhou, Y. Zhuang, L. S. Peng, J. Y. Zhang, Z. N. Yin, X. H. Mao, G. Guo, Y. Shi, and Q. M. Zou. 2012. Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia. BMC Immunol. 13: 38.
121. Nakasone, C., N. Yamamoto, M. Nakamatsu, T. Kinjo, K. Miyagi, K. Uezu, K. Nakamura, F. Higa, H. Ishikawa, R. L. O'Brien, et al. 2007. Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection. Microbes Infect. 9: 251-258.
122. Romani, L., F. Fallarino, A. De Luca, C. Montagnoli, C. D'Angelo, T. Zelante, C. Vacca, F. Bistoni, M. C. Fioretti, U. Grohmann, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
123. Wozniak, K. L., J. K. Kolls, and F. L. Wormley, Jr. 2012. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by gd T cells. BMC Immunol. 13: 65.
124. Spits, H., D. Artis, M. Colonna, A. Diefenbach, J. P. Di Santo, G. Eberl, S. Koyasu, R. M. Locksley, A. N. McKenzie, R. E. Mebius, et al. 2013. Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 13: 145-149.
125. Neill, D. R., S. H. Wong, A. Bellosi, R. J. Flynn, M. Daly, T. K. Langford, C. Bucks, C. M. Kane, P. G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
126. Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
127. Fort, M. M., J. Cheung, D. Yen, J. Li, S. M. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hunte, R. Lesley, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985-995.
128. Price, A. E., H. E. Liang, B. M. Sullivan, R. L. Reinhardt, C. J. Eisley, D. J. Erle, and R. M. Locksley. 2010. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107: 11489-11494.
129. Monticelli, L. A., G. F. Sonnenberg, M. C. Abt, T. Alenghat, C. G. Ziegler, T. A. Doering, J. M. Angelosanto, B. J. Laidlaw, C. Y. Yang, T. Sathaliyawala, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12: 1045-1054.
130. Barlow, J. L., S. Peel, J. Fox, V. Panova, C. S. Hardman, A. Camelo, C. Bucks, X. Wu, C. M. Kane, D. R. Neill, et al. 2013. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. 132: 933-941.
131. Van Maele, L., C. Carnoy, D. Cayet, S. Ivanov, R. Porte, E. Deruy, J. A. Chabalgoity, J. C. Renauld, G. Eberl, A. G. Benecke, et al. 2014. Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. J. Infect. Dis. 210: 493-503.
132. Taube, C., C. Tertilt, G. Gyülveszi, N. Dehzad, K. Kreymborg, K. Schneeweiss, E. Michel, S. Reuter, J. C. Renauld, D. Arnold-Schild, et al. 2011. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS ONE 6: e21799.
133. Kim, H. Y., H. J. Lee, Y. J. Chang, M. Pichavant, S. A. Shore, K. A. Fitzgerald, Y. Iwakura, E. Israel, K. Bolger, J. Faul, et al. 2014. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20: 54-61.
134. Rotta Detto Loria, J., K. Rohmann, D. Droemann, P. Kujath, J. Rupp, T. Goldmann, and K. Dalhoff. 2013. Nontypeable Haemophilus influenzae Infection Upregulates the NLRP3 Inflammasome and Leads to Caspase-1-Dependent Secretion of Interleukin-1β - A Possible Pathway of Exacerbations in COPD. PLoS ONE 8: e66818.
135. Bartziokas, K., A. I. Papaioannou, S. Loukides, A. Papadopoulos, A. Haniotou, S. Papiris, and K. Kostikas. 2014. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur. Respir. J. 43: 43-53.
136. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
137. Weidinger, S., N. Klopp, L. Rummler, S. Wagenpfeil, N. Novak, H. J. Baurecht, W. Groer, U. Darsow, J. Heinrich, A. Gauger, et al. 2005. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J. Allergy Clin. Immunol. 116: 177-184.
138. Kabesch, M., W. Peters, D. Carr, W. Leupold, S. K. Weiland, and E. von Mutius. 2003. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J. Allergy Clin. Immunol. 111: 813-817.
139. Ohar, J. A., R. F. Hamilton, Jr., S. Zheng, A. Sadeghnejad, D. A. Sterling, J. Xu, D. A. Meyers, E. R. Bleecker, and A. Holian. 2010. COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest 137: 1098-1107.
140. Thomsen, M., B. G. Nordestgaard, A. Tybjaerg-Hansen, and M. Dahl. 2011. Scavenger receptor AI/II truncation, lung function and COPD: a large populationbased study. J. Intern. Med. 269: 340-348.
141. Freeman, C. M., J. L. Curtis, and S.W. Chensue. 2007. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am. J. Pathol. 171: 767-776.
142. Urboniene, D., A. Babusyte, J. Lötvall, R. Sakalauskas, and B. Sitkauskiene. 2013. Distribution of gd and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma. Respir. Med. 107: 413-423.
143. Fahy, J. V., and B. F. Dickey. 2010. Airway mucus function and dysfunction. N. Engl. J. Med. 363: 2233-2247.
144. Hayes, E., K. Pohl, N. G. McElvaney, and E. P. Reeves. 2011. The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch. Immunol. Ther. Exp. (Warsz.) 59: 97-112.
145. Hoenderdos, K., and A. Condliffe. 2013. The neutrophil in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 48: 531-539.
146. Mizgerd, J. P. 2008. Acute lower respiratory tract infection. N. Engl. J. Med. 358: 716-727.